Translational Research

Revolutionary Drug Delivery Platform: Improves Effectiveness and Tolerability of Cancer Treatments

THE CHALLENGE——Patient Circumstances Limit Potential Viable Therapies Patients afflicted with tumors and cancers are in need of urgent, active intervention in order to have the best possibilities for treatment success and a favorable outcome. The majority of such patients often present with additional underlying conditions which complicate therapeutic decision-making and…...

Read more

Engaging the Immune System to Treat Gastrointestinal Cancers

THE CHALLENGE ——High Incidence and Mortality, Few Viable and Dedicated Drugs Gastrointestinal (GI) cancers including colorectal, stomach, liver, esophageal, and pancreas have high incidence and mortality. Globally, they have the 2nd, 3rd, 4th, 6th, and 7th largest death tolls, respectively, among all cancers. In 2020, stomach, pancreatic, and colon cancers…...

Read more

Multi-functional antibodies to target cancer on multiple fronts

Advanced cancers typically suppress the immune response by multiple mechanisms. By carefully engineering multi-functional antibody therapies, there is the potential for more effective treatment....

Read more

Determining the Risk of Hereditary Breast and Ovarian Cancer (HBOC) in China

Understanding the risk of breast cancer in the Chinese population is very important due to the exponential increase in incidence......

Read more

Gastric Cancer Research

Gastric cancer is the fourth most common cancer and the second leading cause of cancer death worldwide....

Read more

Tissue Bank Consortium in Asia

Integrating international resources to promote collaboration and accelerate cancer research...

Read more